These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 11157561

  • 21. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
    Liu K, Olofsson JI, Wahlberg P, Ny T.
    Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
    [Abstract] [Full Text] [Related]

  • 22. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V, Kristiansen GO, Johannsen M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [Abstract] [Full Text] [Related]

  • 23. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
    Wilton E, Bland M, Thompson M, Jahangiri M.
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
    [Abstract] [Full Text] [Related]

  • 24. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
    Wang X, Li Y, Chen J, Guo X, Guan H, Li C.
    Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
    [Abstract] [Full Text] [Related]

  • 25. Identification of matrix metalloproteinases and their tissue inhibitors type 1 and 2 in human masseter muscle.
    Singh A, Nelson-Moon ZL, Thomas GJ, Hunt NP, Lewis MP.
    Arch Oral Biol; 2000 Jun; 45(6):431-40. PubMed ID: 10775672
    [Abstract] [Full Text] [Related]

  • 26. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat.
    Curry TE, Song L, Wheeler SE.
    Biol Reprod; 2001 Sep; 65(3):855-65. PubMed ID: 11514351
    [Abstract] [Full Text] [Related]

  • 27. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 28. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.
    Galboiz Y, Shapiro S, Lahat N, Rawashdeh H, Miller A.
    Ann Neurol; 2001 Oct; 50(4):443-51. PubMed ID: 11601495
    [Abstract] [Full Text] [Related]

  • 29. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ, van Muijen GN.
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [Abstract] [Full Text] [Related]

  • 30. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV.
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [Abstract] [Full Text] [Related]

  • 31. Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.
    Satta J, Oiva J, Salo T, Eriksen H, Ohtonen P, Biancari F, Juvonen TS, Soini Y.
    Ann Thorac Surg; 2003 Sep; 76(3):681-8; discussion 688. PubMed ID: 12963177
    [Abstract] [Full Text] [Related]

  • 32. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas.
    Zhang X, Wang Y, Yamamoto G, Tachikawa T.
    Histopathology; 2009 Sep; 55(3):250-60. PubMed ID: 19723139
    [Abstract] [Full Text] [Related]

  • 33. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S, Trovato MJ, You R, Lal BK, Fasehun F, Padberg FT, Hobson RW, Durán WN, Pappas PJ.
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [Abstract] [Full Text] [Related]

  • 34. Tamoxifen-induced alterations in the expression of selected matrix metalloproteinases (MMP-2, -9, -10, and -13) and their tissue inhibitors (TIMP-2 and -3) in the chicken ovary.
    Wolak D, Hrabia A.
    Theriogenology; 2020 May; 148():208-215. PubMed ID: 31753476
    [Abstract] [Full Text] [Related]

  • 35. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair.
    Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K.
    Plast Reconstr Surg; 2000 Feb; 105(2):638-47. PubMed ID: 10697171
    [Abstract] [Full Text] [Related]

  • 36. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
    Bai G, Howell DS, Howard GA, Roos BA, Cheung HS.
    Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
    [Abstract] [Full Text] [Related]

  • 37. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the regression of chicken postovulatory follicles.
    Hrabia A, Socha JK, Sechman A.
    Gen Comp Endocrinol; 2018 May 01; 260():32-40. PubMed ID: 29438675
    [Abstract] [Full Text] [Related]

  • 38. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit.
    Feldman LJ, Mazighi M, Scheuble A, Deux JF, De Benedetti E, Badier-Commander C, Brambilla E, Henin D, Steg PG, Jacob MP.
    Circulation; 2001 Jun 26; 103(25):3117-22. PubMed ID: 11425778
    [Abstract] [Full Text] [Related]

  • 39. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D, Hrynyschyn K, Pallua N.
    Plast Reconstr Surg; 2003 Oct 26; 112(5):1279-86. PubMed ID: 14504511
    [Abstract] [Full Text] [Related]

  • 40. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14.
    Filanti C, Dickson GR, Di Martino D, Ulivi V, Sanguineti C, Romano P, Palermo C, Manduca P.
    J Bone Miner Res; 2000 Nov 26; 15(11):2154-68. PubMed ID: 11092396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.